Future investigation is warranted to elucidate the detailed mechanisms of antioxidant signaling pathways in Parkinson's disease and to develop possible interventions targeting NFE2L2-ARE pathways for neurodegenerative disease therapy. This evidence concerns the gene NFE2L2 and neurodegenerative disease.